{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T17:32:29Z","timestamp":1788802349955,"version":"build-2803163510"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T00:00:00Z","timestamp":1613606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Peking University People\u2019s Hospital Research and Development Funds","award":["RDX 2019-02"],"award-info":[{"award-number":["RDX 2019-02"]}]},{"name":"Peking University People\u2019s Hospital Research and Development Funds","award":["(RDH2020-03"],"award-info":[{"award-number":["(RDH2020-03"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Retroperitoneal fibrosis (RPF) is an uncommon condition characterized by inflammation and fibrosis in the retroperitoneal space. More than two-thirds of RPF are idiopathic, with the remaining stemed from a variety of secondary causes. It was suggested that IgG4-related RPF is a secondary form of RPF. We undertook this study to compare detailed demographic, clinical and laboratory characteristics of IgG4-related RPF and IRPF in a large Chinese cohort. We retrospectively reviewed the medical records of 132 RPF patients diagnosed at Peking University People\u2019s Hospital between March 2010 and March 2018. Among the 132 patients, the mean age at disease onset was 54.8 years. IgG4-related RPF group showed greater male predominance compared to IRPF group. IgG4-related RPF patients showed a longer interval between symptom onset and diagnosis, and allergic diseases were more common in this group. Sixty-four patients (48.4%) had lower back pain, which was more common in IRPF group than that in IgG4-related RPF patients. In terms of organ involvement, although 42 of 47 patients (89.3%) with IgG4-related RPF had other organ involvement, there were no patients in the IRPF group with other organ involvement. In addition, the serum IgG4 level, elevated eosinophils counts and IgE level were significantly higher in IgG4-related RPF patients. We described the demographic, clinical and laboratory differences between IgG4-related RPF and IRPF patients, indicating their potential differences in pathogenesis, which was of great importance to diagnose and manage the two phenotypes.<\/jats:p>","DOI":"10.1371\/journal.pone.0245601","type":"journal-article","created":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T18:40:24Z","timestamp":1613673624000},"page":"e0245601","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":28,"title":["Clinical characteristics of IgG4-related retroperitoneal fibrosis versus idiopathic retroperitoneal fibrosis"],"prefix":"10.1371","volume":"16","author":[{"given":"Kunkun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenfan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaozhu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danhua","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2609-4052","authenticated-orcid":true,"given":"Yanying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,2,18]]},"reference":[{"issue":"7","key":"pone.0245601.ref001","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1681\/ASN.2015101110","article-title":"Idiopathic Retroperitoneal Fibrosis","volume":"27","author":"A Vaglio","year":"2016","journal-title":"Journal of the American Society of Nephrology: JASN"},{"issue":"2","key":"pone.0245601.ref002","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.rdc.2013.02.004","article-title":"Retroperitoneal fibrosis","volume":"39","author":"PJ Scheel","year":"2013","journal-title":"Rheumatic diseases clinics of North America"},{"issue":"9506","key":"pone.0245601.ref003","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(06)68035-5","article-title":"Retroperitoneal fibrosis","volume":"367","author":"A Vaglio","year":"2006","journal-title":"Lancet (London, England)"},{"issue":"3","key":"pone.0245601.ref004","first-page":"250","article-title":"The clinical significance of retroperitoneal fibrosis","volume":"81","author":"L Koep","year":"1977","journal-title":"Surgery"},{"issue":"9976","key":"pone.0245601.ref005","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/S0140-6736(14)60720-0","article-title":"IgG4-related disease","volume":"385","author":"T Kamisawa","year":"2015","journal-title":"Lancet (London, England)"},{"issue":"5","key":"pone.0245601.ref006","first-page":"605","article-title":"IgG4-related disease","volume":"63","author":"M Ebbo","year":"2013","journal-title":"La Revue du praticien"},{"issue":"4","key":"pone.0245601.ref007","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1053\/j.semdp.2012.08.002","article-title":"IgG4-related disease: nomenclature, clinical features, and treatment","volume":"29","author":"JH Stone","year":"2012","journal-title":"Seminars in diagnostic pathology"},{"issue":"1","key":"pone.0245601.ref008","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/BOR.0b013e3283418057","article-title":"A clinical overview of IgG4-related systemic disease","volume":"23","author":"A Khosroshahi","year":"2011","journal-title":"Current opinion in rheumatology"},{"issue":"1","key":"pone.0245601.ref009","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/BOR.0b013e3283412f7c","article-title":"Aortitis, periaortitis, and retroperitoneal fibrosis, as manifestations of IgG4-related systemic disease","volume":"23","author":"JR Stone","year":"2011","journal-title":"Current opinion in rheumatology"},{"key":"pone.0245601.ref010","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1146\/annurev-pathol-012513-104708","article-title":"IgG4-related disease","volume":"9","author":"VS Mahajan","year":"2014","journal-title":"Annual review of pathology"},{"issue":"3","key":"pone.0245601.ref011","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s11739-016-1599-z","article-title":"Idiopathic retroperitoneal fibrosis and its overlap with IgG4-related disease","volume":"12","author":"GM Rossi","year":"2017","journal-title":"Internal and emergency medicine"},{"issue":"2","key":"pone.0245601.ref012","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/MD.0b013e318289610f","article-title":"Rethinking Ormond\u2019s disease: \"idiopathic\" retroperitoneal fibrosis in the era of IgG4-related disease","volume":"92","author":"A Khosroshahi","year":"2013","journal-title":"Medicine"},{"issue":"2","key":"pone.0245601.ref013","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3109\/14397595.2014.931908","article-title":"Clinicopathologic characteristics of IgG4-related retroperitoneal fibrosis among patients initially diagnosed as having idiopathic retroperitoneal fibrosis","volume":"25","author":"BS Koo","year":"2015","journal-title":"Modern rheumatology"},{"issue":"1","key":"pone.0245601.ref014","doi-asserted-by":"crossref","first-page":"42","DOI":"10.23876\/j.krcp.18.0052","article-title":"Retroperitoneal fibrosis in the era of immunoglobulin G4-related disease","volume":"38","author":"YK Choi","year":"2019","journal-title":"Kidney research and clinical practice"},{"issue":"1","key":"pone.0245601.ref015","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/s10165-011-0571-z","article-title":"Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011","volume":"22","author":"H Umehara","year":"2012","journal-title":"Modern rheumatology"},{"issue":"12","key":"pone.0245601.ref016","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/j.cgh.2018.02.049","article-title":"Rituximab Maintenance Therapy Reduces Rate of Relapse of Pancreaticobiliary Immunoglobulin G4-related Disease","volume":"16","author":"S Majumder","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"pone.0245601.ref017","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s00535-018-1434-6","article-title":"Relapse rate and predictors of relapse in a large single center cohort of type 1 autoimmune pancreatitis: long-term follow-up results after steroid therapy with short-duration maintenance treatment","volume":"53","author":"HW Lee","year":"2018","journal-title":"J Gastroenterol"},{"issue":"42","key":"pone.0245601.ref018","doi-asserted-by":"crossref","first-page":"e12631","DOI":"10.1097\/MD.0000000000012631","article-title":"Rituximab for idiopathic and IgG4-related retroperitoneal fibrosis","volume":"97","author":"R Wallwork","year":"2018","journal-title":"Medicine"},{"issue":"1","key":"pone.0245601.ref019","doi-asserted-by":"crossref","first-page":"10262","DOI":"10.1038\/s41598-018-28405-x","article-title":"Factors in glucocorticoid regimens associated with treatment response and relapses of IgG4-related disease: a multicentre study","volume":"8","author":"M Shirakashi","year":"2018","journal-title":"Sci Rep"},{"issue":"4","key":"pone.0245601.ref020","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/MD.0b013e3181afc420","article-title":"Idiopathic retroperitoneal fibrosis: prospective evaluation of incidence and clinicoradiologic presentation","volume":"88","author":"EF van Bommel","year":"2009","journal-title":"Medicine"},{"issue":"7","key":"pone.0245601.ref021","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1093\/rheumatology\/keu462","article-title":"IgG4-related periaortitis vs idiopathic periaortitis: is there a role for atherosclerotic plaque in the pathogenesis of IgG4-related periaortitis?","volume":"54","author":"T Castelein","year":"2015","journal-title":"Rheumatology (Oxford, England)"},{"issue":"12","key":"pone.0245601.ref022","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1097\/PAS.0b013e3181b72882","article-title":"Retroperitoneal fibrosis: a clinicopathologic study with respect to immunoglobulin G4","volume":"33","author":"Y Zen","year":"2009","journal-title":"The American journal of surgical pathology"},{"key":"pone.0245601.ref023","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3389\/fimmu.2019.00693","article-title":"Clinical and Prognostic Significance of Serum IgG4 in Chronic Periaortitis. An Analysis of 113 Patients","volume":"10","author":"F Maritati","year":"2019","journal-title":"Front Immunol"},{"issue":"3","key":"pone.0245601.ref024","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1365-2559.2007.02959.x","article-title":"Degree of IgG4+ plasma cell infiltration in retroperitoneal fibrosis with or without multifocal fibrosclerosis","volume":"52","author":"K Yamashita","year":"2008","journal-title":"Histopathology"},{"issue":"6","key":"pone.0245601.ref025","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/hep.21697","article-title":"Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis","volume":"45","author":"Y Zen","year":"2007","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"12","key":"pone.0245601.ref026","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s00380-018-1203-8","article-title":"Inflammatory features, including symptoms, increased serum interleukin-6, and C-reactive protein, in IgG4-related vascular diseases","volume":"33","author":"S Kasashima","year":"2018","journal-title":"Heart and vessels"},{"issue":"4","key":"pone.0245601.ref027","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/MD.0b013e3181afc439","article-title":"Retroperitoneal fibrosis: the clinical, laboratory, and radiographic presentation","volume":"88","author":"PJ Scheel","year":"2009","journal-title":"Medicine"},{"issue":"6","key":"pone.0245601.ref028","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMra1104650","article-title":"IgG4-related disease","volume":"366","author":"JH Stone","year":"2012","journal-title":"The New England journal of medicine"},{"issue":"5","key":"pone.0245601.ref029","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3109\/00365599.2012.747564","article-title":"Retroperitoneal fibrosis: single-centre experience from 1992 to 2010, current status of knowledge and review of the international literature","volume":"47","author":"I Gomez Garcia","year":"2013","journal-title":"Scandinavian journal of urology"},{"issue":"1","key":"pone.0245601.ref030","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/art.20914","article-title":"(18)F-fluorodeoxyglucose positron emission tomography in the diagnosis and followup of idiopathic retroperitoneal fibrosis","volume":"53","author":"A Vaglio","year":"2005","journal-title":"Arthritis and rheumatism"},{"issue":"9788","key":"pone.0245601.ref031","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0140-6736(11)60934-3","article-title":"Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open-label randomised controlled trial","volume":"378","author":"A Vaglio","year":"2011","journal-title":"Lancet (London, England)"},{"issue":"5","key":"pone.0245601.ref032","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1053\/j.ajkd.2007.02.268","article-title":"Long-term renal and patient outcome in idiopathic retroperitoneal fibrosis treated with prednisone. American journal of kidney diseases: the official journal of the","volume":"49","author":"EF van Bommel","year":"2007","journal-title":"National Kidney Foundation"},{"issue":"8","key":"pone.0245601.ref033","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1093\/rheumatology\/kez669","article-title":"Relapse predictors and serologically unstable condition of IgG4-related disease: a large Chinese cohort","volume":"59","author":"Y Liu","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"pone.0245601.ref034","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1002\/art.39205","article-title":"IgG4-Related Disease: Clinical and Laboratory Features in One Hundred Twenty-Five Patients","volume":"67","author":"ZS Wallace","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"pone.0245601.ref035","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1136\/gut.2008.172908","article-title":"Standard steroid treatment for autoimmune pancreatitis","volume":"58","author":"T Kamisawa","year":"2009","journal-title":"Gut"},{"issue":"11","key":"pone.0245601.ref036","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1002\/acr.23543","article-title":"An International Multispecialty Validation Study of the IgG4-Related Disease Responder Index","volume":"70","author":"ZS Wallace","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0245601","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T18:40:55Z","timestamp":1613673655000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0245601"}},"subtitle":[],"editor":[{"given":"Jan H.N.","family":"Lindeman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,2,18]]},"references-count":36,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0245601","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,18]]}}}